Selecta Biosciences, Inc.
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

Last updated:

Abstract:

Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.

Status:
Grant
Type:

Utility

Filling date:

11 Jun 2019

Issue date:

12 Apr 2022